|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006826,
umls-concept:C0008838,
umls-concept:C0029246,
umls-concept:C0034656,
umls-concept:C0035168,
umls-concept:C0039512,
umls-concept:C0086960,
umls-concept:C0087111,
umls-concept:C0205179,
umls-concept:C0239307,
umls-concept:C0684249,
umls-concept:C1521808,
umls-concept:C1554217,
umls-concept:C2603343
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1996-2-23
|
|
pubmed:abstractText |
We conducted a randomized trial to investigate the value of the addition of cisplatin to teniposide (VM26) and to investigate the schedule dependence of the topoisomerase II inhibitor VM26, in advanced non-small-cell lung cancer (NSCLC) patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:BurghoutsJJ,
pubmed-author:ClericoMM,
pubmed-author:DautzenbergBB,
pubmed-author:FestenJJ,
pubmed-author:GiacconeGG,
pubmed-author:KhoG SGS,
pubmed-author:KirkpatrickAA,
pubmed-author:SörensonSS,
pubmed-author:SahmoudTT,
pubmed-author:SplinterT ATA,
pubmed-author:van ZandwijkNN
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
127-34
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:8558187-Adult,
pubmed-meshheading:8558187-Aged,
pubmed-meshheading:8558187-Alopecia,
pubmed-meshheading:8558187-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8558187-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:8558187-Cisplatin,
pubmed-meshheading:8558187-Diarrhea,
pubmed-meshheading:8558187-Disease-Free Survival,
pubmed-meshheading:8558187-Factor Analysis, Statistical,
pubmed-meshheading:8558187-Female,
pubmed-meshheading:8558187-Hematologic Diseases,
pubmed-meshheading:8558187-Humans,
pubmed-meshheading:8558187-Lung Neoplasms,
pubmed-meshheading:8558187-Male,
pubmed-meshheading:8558187-Middle Aged,
pubmed-meshheading:8558187-Peripheral Nervous System Diseases,
pubmed-meshheading:8558187-Proportional Hazards Models,
pubmed-meshheading:8558187-Survival Rate,
pubmed-meshheading:8558187-Teniposide,
pubmed-meshheading:8558187-Topoisomerase II Inhibitors
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Two schedules of teniposide with or without cisplatin in advanced non-small-cell lung cancer: a randomized study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
|
|
pubmed:affiliation |
University Hospital Dijkzigt, Rotterdam, The Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
